MDISS expands cybersecurity standards to connected medical systems
Category: #health  By Shikha Sinha  Date: 2019-02-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

MDISS expands cybersecurity standards to connected medical systems

A nonprofit patient safety and public health organization, Medical Device Innovation, Safety, and Security Consortium (MDISS), has recently announced the development of a set of recommended profiles and practices to secure medical systems, based on normative requirements in widely utilized ISA/IEC 62443 standard series for control systems and industrial automation cybersecurity.

Apparently, the intention for this development is to share information across the MDISS member organization network, including insurance companies, hospital networks, healthcare software companies and medical device manufacturers.

Executive Director of MDISS, Dr. Dale Nordenberg, mentioned that MDISS is committed towards improving the state of cybersecurity in medical devices and systems for reducing risks among patients. The organization views the ISA/IEC 62443 standards as delivering a strong basis for recommended practices in this area and to develop comprehensive profiles, he said.

The ISA/IEC 62443 standards have mainly been developed by the International Society of Automation’s ISA99 committee, with simultaneous adoption and review by the International Electrotechnical Commission based in Geneva. ISA99 draws on the input from cybersecurity experts from around the world for developing standards in a consensus, balanced process which is accredited by the American National Standards Institute.

According to reports, these standards are applicable for all critical infrastructure and industry sectors, offering a comprehensive and flexible framework for addressing and mitigating current and future security vulnerabilities in industrial control and automation systems.

Eric Cosman, Co-chair of ISA99, pointed out that application to connected medical devices exhibits the increasing use of the standards across various sectors globally. He added that the organization deliberately stated its scope in terms of potential consequences, when the committee was first formed, rather than limiting to specific industries.

Cosman further said that this decision has served the organization well as the standards have also been extended to building automation, rail transportation, and now medical systems, rather than being limited to industrial processing and traditional manufacturing sectors.



About Author

Shikha Sinha

Email: [email protected]   

Shikha Sinha

Shikha currently manages content operations for a series of news and business portals including MSF, Algosonline, and the like. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market resea...

Read More

More News By Shikha Sinha

Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
By Shikha Sinha

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquisition of Spitfire Pharma, Inc., including the strong GLP-1/Glucagon receptor co-agonist product cand...

NeurologyLive expands SAP program by partnering with Cleveland Clinic
NeurologyLive expands SAP program by partnering with Cleveland Clinic
By Shikha Sinha

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J. Hennessy Jr., President of NeurologyLive’s parent company MJH Associates Inc., said in a sta...

Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
By Shikha Sinha

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from the VY-AADC trial in eight patients suffering from Parkinson’s disease. Apparently, the patient...